secwatch / observer
8-K filed May 14, 2024, 7:59 PM ET ticker GNSS CIK 0000924383
other material confidence high sentiment negative materiality 0.85

Genasys Inc. (GNSS): debt financing — Genasys Q2 revenue $5.7M (-49% YoY), net loss $0.16/sh; Puerto Rico EWS expanded to $75M; $15M secured loan closed

Genasys Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bill Dodd

Director
GNSS · Genasys Inc.
Effective
2024-06-01
Filed
May 14, 2024, 7:59 PM ET
the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024
Appointed

Craig Fugate

Director
GNSS · Genasys Inc.
Effective
2024-06-01
Filed
May 14, 2024, 7:59 PM ET
the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Genasys Inc. incurred term loan of $15,000,000 with Cantor Fitzgerald Securities at three-month SOFR plus five percent maturing May 13, 2026.

Instrument
term loan
Principal
$15,000,000
Counterparty
Cantor Fitzgerald Securities
Rate
three-month SOFR plus five percent
Maturity
May 13, 2026
Event
incurrence
Exact text from the filing
On May 13, 2024, Genasys Inc. (the “Company”) entered into (a) a Term Loan and Security Agreement (the “Loan Agreement”) among the Company, Evertel Technologies, LLC (“Evertel”), Zonehaven LLC (“Zonehaven”), Genasys Puerto Rico, LLC (“Genasys PR”), the lenders from time to time party thereto (the “Lenders”) and Cantor Fitzgerald Securities, as administrative agent and collateral agent, pursuant to which the Company borrowed Fifteen Million Dollars ($15,000,000) (the “Loan Transaction”)
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Genasys Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $5.7 million, net income ($6.9) million, EPS ($0.16).

Period
the fiscal quarter ended March 31, 2024
Revenue
$5.7 million
Net income
($6.9) million
EPS
($0.16)
Result
reported results
Exact text from the filing
of the software business rapidly growing. We are more confident in the long-term health of our business than we have ever been.” Fiscal 2Q 2024 Financial Summary ● Revenue of $5.7 million, versus $11.2 million in 2Q 2023 ● GAAP operating loss of ($6.9) million, versus ($3.4) million in 2Q 2023. ● GAAP net loss of ($6.9) million versus ($3.4) million in 2Q 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Bill Dodd was appointed as Director at Genasys Inc..

Action
appointed
Role
Director
Exact text from the filing
the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Craig Fugate was appointed as Director at Genasys Inc..

Action
appointed
Role
Director
Exact text from the filing
the Company announced the appointment of Bill Dodd and Craig Fugate to the Board of Directors (the “Board”) of the Company effective June 1, 2024
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Genasys Inc. entered into Right of First Refusal Agreement with Cantor Fitzgerald Securities valued at Right of first refusal on equity or debt financings during first year (effective 2024-05-13).

Action
entry
Counterparty
Cantor Fitzgerald Securities
Value
Right of first refusal on equity or debt financings during first year
Effective
2024-05-13
Exact text from the filing
the Company also entered into a Right of First Refusal Agreement (the “ROFR Agreement”), pursuant to which the Company granted to the Lenders a right of first refusal with respect to equity or debt financings completed by the Company during the first year following the closing of the Loan Transaction
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Genasys Inc. entered into Warrant Agreement with Cantor Fitzgerald Securities valued at Warrants to purchase up to 3,068,182 shares of common stock, exercise price $2.53 per share (effective 2024-05-13).

Action
entry
Counterparty
Cantor Fitzgerald Securities
Value
Warrants to purchase up to 3,068,182 shares of common stock, exercise price $2.53 per share
Effective
2024-05-13
Exact text from the filing
(b) a Warrant Agreement (the “Warrant Agreement”) pursuant to which the Company agreed to issue to the Lenders warrants (the “Warrants”) to purchase up to 3,068,182 shares of the Company’s common stock at an initial exercise price of $2.53 per share
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Genasys Inc. entered into Term Loan and Security Agreement with Cantor Fitzgerald Securities valued at $15,000,000 borrowed, warrants to purchase up to 3,068,182 shares at $2.53 per share, interest SOFR+ (effective 2024-05-13).

Action
entry
Agreement
credit facility
Counterparty
Cantor Fitzgerald Securities
Value
$15,000,000 borrowed, warrants to purchase up to 3,068,182 shares at $2.53 per share, interest SOFR+
Effective
2024-05-13
Exact text from the filing
On May 13, 2024, Genasys Inc. (the “Company”) entered into (a) a Term Loan and Security Agreement (the “Loan Agreement”) among the Company, Evertel Technologies, LLC (“Evertel”), Zonehaven LLC (“Zonehaven”), Genasys Puerto Rico, LLC (“Genasys PR”), the lenders from time to time party thereto (the “Lenders”) and Cantor Fitzgerald Securities, as administrative agent and collateral agent, pursuant to which the Company borrowed Fifteen Million Dollars ($15,000,000) (the “Loan Transaction”)
View on SEC.gov

305 debt financings filed in the last 30 days. Browse all debt financings →

Genasys Inc. filing history →

Source: SEC EDGAR
accession 0001437749-24-016642
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.